27 March 2005

Healthcare Coverage in the U.S.



Change In Challenging Times: A Plan For Extending And Improving Health Coverage

Jeanne M. Lambrew, John D. Podesta, Teresa L. Shaw
Health Affairs, 10.1377/w5.119-132

By any objective standard the U.S. health care system has serious problems, which are getting worse. Since 2000 the number of uninsured Americans has risen by five million, to forty-five million or nearly 16 percent of all Americans. There are more uninsured Americans than the total population of Canada or people living worldwide with AIDS; the uninsurance rate is three times higher than the unemployment rate. Health insurancematters, according to a recent review by the Institute of Medicine (IOM), which found that uninsured people tend to have worse health outcomes because of delayed and sometimes denied care and are treated differently once in the system.

The lack of coverage exacts a large personal financial toll, running up debt and contributing to personal bankruptcy. It also results in billions of dollars in uncompensated care costs that get passed along through the health system. Uninsurance is perhaps the most important, but not the only, problem in the system. In 2004 the cost of employer based health benefits increased at a rate five times higher than that of wages; since 2000 the family share of such coverage increased by more than 60 percent. This not only strains the middle class but also limits employers’ willingness to create jobs.

For all we pay, we have worse-than-expected health: lower life expectancy than more than twenty other countries, near-epidemics of preventable conditions, and an infant mortality rate that rose in 2002 for the first time in forty years. Yet as the public policy agenda rolls out for 2005, major health proposals are nowhere in sight.

President George W. Bush did not include new ideas for expanding coverage in the State of the Union address or his budget. Also, Congress seems intent on scaling back rather than stepping up federal funding to solve health system problems. This lack of political attention is not for lack of public support. We know that people recognize the problem: Among 2004 election voters, 93 percent were concerned about the availability and affordability of health care.

25 March 2005

Fish Oil Supplements Reduce Death Rate in Heart Patients By 45%


Recently, I was reviewing the Lyon Heart Study in preparing a presentation for the Future of Health Technology Summit at the MIT. The 70% reduction in mortality experienced by people on a Mediterranean diet was largely due to consumption of Omega 3 fatty acids found in fish oil! Folks, this stuff will not only help you run faster, think smarter, improve heart and brain function, and reduce the incidence of multiple diseases, it could save your life! I've tried multiple kinds of fish oil and like the Sears Laboratory liquid form best. I take it every day without fail.

In a report released by the American Heart Association, fish oil supplements were shown to drastically reduce the risk of sudden death. The study consisted of 11,323 patients who had suffered a heart attack within the previous three months. All of the patients were told to eat diets rich in fruits, vegetables, olive oil and fish. One group of these patients was also given 1000 mg a day of a fish oil supplement. After only three months of fish oil treatment, there was an astounding 41% decrease in the risk of sudden death. At the end of the three-and-a-half-year study, those receiving the fish oil supplement were 45% less likely to die from a heart-related disease.

The doctors who published this study stated that the reason fish oil prevented sudden death is that it lowered the risk of fatal arrhythmia. Most sudden death heart attacks are caused by a lethal fibrillation event, where the heart muscle beats wildly out of control and does not pump any blood. The only way of saving a person in a state of “ventricular fibrillation” is to immediately apply a “defibrillator” that shocks them back into a normal rhythm. Fish oil functions as an “anti-arrhythmic” agent to prevent lethal fibrillations.

They have portable defibrillators now in some malls and airports. Avoid letting an amateur (or even a professional) try one out on you. Take your fish oil. And remember it needs to be pharmaceutical grade.

Circulation. 2002;105:1897
Clinical Investigation and Reports
Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction
Roberto Marchioli, MD et. al.

23 March 2005

What are H. Pylori Frequencies?


Many people have asked for frequencies for H. Pylori as it is often resistant to antibiotics. I have updated the frequencies based on seeing many more cases of H. Pylori.

The photos above are from Barry Marshall's picture book of H. Pylori. The one on the right is from a biopsy of his stomach after drinking a beaker full of the bacteria.

Frequencies can vary with different strains of organisms in different people, or there may be multiple strains in a single individual. Is this case, the frequency of the organism in both pictures is 268647hz with a bandwidth of 28hz. When bacteria are killed they appear to always release a toxic protein with a frequency in the 9000-12000hz range. The protein frequency for this strain of H. Pylori is 10655hz with a bandwidth of 4hz. Both freqencies should be targeted.

I've received requests on how to run these frequencies on an F160. Currently, I am running a unique combination of carrier frequency that is a scalar octave of the original frequency. It takes advantage of the unique characteristics of the F160 and shortens run times dramatically. I leave it to the reader as a exercise to figure out why this works as it cannot be explained in a short note. Documentation of this programming language can be found in the F160 manual.

repeat 10
dwell 240
duty 50
program b
vbackfreq a 20.08554 0 50
converge 2.1 .01
#268647 #original frequency X
13375.14 #scalar octave = X/exp(3)
10655 #toxic protein
end repeat

About an hour with a pad or plasma unit will be required to eliminate this pathogen, preferably plate zapping for half the time with a microscopic slide of stomach tissue. Plate zapping introduces target tissue into the electromagnetic field of the frequency generator and acts as an electronic filter which alters the impedance match of the field to target tissue. As a result, about four times more energy in the electromagnetic field will resonate with target tissue.

If these frequencies do not work the first time, H. Pylori may not be present, or the strain present may have been modified in the process of becoming resistant to antibiotics. A slightly different frequency might be required and the frequency would need to be tested for with the infected individual. A high resolution digital photo is required for this.


Google Groups Electronic Medicine
Browse Archives at groups-beta.google.com

22 March 2005

LifeWave Alternative to Steroids


Steroids and other "chemicals" are dangerous. LifeWave Energy Enhancer patches are training aids that provides a clear alternative to taking banned and potentially harmful substances such as steroids and even chemical and herbal stimulants.

LifeWave's non transdermal Energy Enhancer patches are designed to increase a person's energy, stamina, and performance by sending bio-informational signals into the human body instead of chemicals. LifeWave energy patches work even though nothing enters the body except information signals. Athletes, Soccer Moms, the elderly and many others are looking for that "edge" with an added boost of energy to get them through the day. The uses are endless from playing the final 3 holes of a golf course, getting through an exhausting business trip, studying for exams, driving long distances, working in the garden, and so on.

Consumers are looking for the edge that will make their lives easier and enable them to get more out of their day and life. Consider: Nike sells that special shoe to help an athlete perform. Calloway Golf sells that special oversized driver to help you hit the ball further. Olympic athletes wear special swim suits to help them swim faster. And, LifeWave sells a patch to improve your energy and stamina. All these products offer different strategies for individuals to meet or exceed their personal goals. The consumer demands products that supply "the edge" in their daily life. The LifeWave Energy Enhancer supports this need. However, it is not a banned substance as it is non transdermal.

Is LifeWave like a steroid? Can LifeWave show up in the body?

Absolutely not! LifeWave Energy Enhancer patches are training aids that tell the body, through a naturally occurring process, to increase energy, stamina, and performance. Many athletes who use the LifeWave Energy Enhancer patch have been "drug tested". This includes College and Olympic athletes where stringent testing and guidelines are followed. Testing includes blood analysis and urine analysis. As might be expected, since no chemicals enter the body, there is nothing to test for. You cannot test for something that is not there.

I am an athlete! What can I expect from LifeWave?

First of all, you will experience an increased level of energy. It will not appear as a "caffeine buzz" or any other form of heightened awareness, but as an overall increase in energy, stamina, and performance. In double blind placebo controlled studies with athletes, we have found a 20% increase, on the low side, with an average increase of approximately 40%. People that have a regular fitness program to measure the "before and after" can clearly see the difference.

What does this mean to me?

The patches will help you train better and longer as your stamina increases. Anecdotally, athletes have reported that they are able to get to "the next level" in their training regime with the help of the patches. This is a clear alternative to dangerous steroids or drugs. "LifeWave Energy Enhancer patches are training aids that tell the body, through a naturally occurring process, to increase energy, stamina, and performance."

20 March 2005

Alternative Medicine Patterns of Use


Unconventional medicine in the United States. Prevalence, costs, and patterns of use
Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL.
Department of Medicine, Beth Israel Hospital, Boston, MA 02215.
N Engl J Med. 1993 Jan 28;328(4):246-52

BACKGROUND.
Many people use unconventional therapies for health problems, but the extent of this use and the costs are not known. We conducted a national survey to determine the prevalence, costs, and patterns of use of unconventional therapies, such as acupuncture and chiropractic.
METHODS. We limited the therapies studied to 16 commonly used interventions neither taught widely in U.S. medical schools nor generally available in U.S. hospitals. We completed telephone interviews with 1539 adults (response rate, 67 percent) in a national sample of adults 18 years of age or older in 1990. We asked respondents to report any serious or bothersome medical conditions and details of their use of conventional medical services; we then inquired about their use of unconventional therapy.
RESULTS. One in three respondents (34 percent) reported using at least one unconventional therapy in the past year, and a third of these saw providers for unconventional therapy. The latter group had made an average of 19 visits to such providers during the preceding year, with an average charge per visit of $27.60. The frequency of use of unconventional therapy varied somewhat among socio-demographic groups, with the highest use reported by nonblack persons from 25 to 49 years of age who had relatively more education and higher incomes. The majority used unconventional therapy for chronic, as opposed to life-threatening, medical conditions. Among those who used unconventional therapy for serious medical conditions, the vast majority (83 percent) also sought treatment for the same condition from a medical doctor; however, 72 percent of the respondents who used unconventional therapy did not inform their medical doctor that they had done so. Extrapolation to the U.S. population suggests that in 1990 Americans made an estimated 425 million visits to providers of unconventional therapy. This number exceeds the number of visits to all U.S. primary care physicians (388 million). Expenditures associated with use of unconventional therapy in 1990 amounted to approximately $13.7 billion, three quarters of which ($10.3 billion) was paid out of pocket. This figure is comparable to the $12.8 billion spent out of pocket annually for all hospitalizations in the United States.
CONCLUSIONS. The frequency of use of unconventional therapy in the United States is far higher than previously reported. Medical doctors should ask about their patients' use of unconventional therapy whenever they obtain a medical history.

18 March 2005

Medical Error: The Public Perception

People ask me what I do for my day job. I work on helping physicians save time, save money, and save lives using medical informatics. I'm currently finishing up a paper on using information technology to build an autopilot for healthcare that will be published as a chapter in a least two books. One of my surgeon co-authors has pushed me into expanding the section on medical error. Simultaneously, old friends are calling me from the hospital and asking me to talk to their physicians about medical error they are experiencing in real time.

Since this site is dedicated to those who wish to live long and prosper, understanding this problem and developing strategies to deal with it are essential to avoid becoming a mortality statistic. Inpatient iatrogenic medical error is the third leading cause of death and all sources of medical error (inpatient, outpatient, nursing home, etc.) is the leading cause of death. I intend to post several notes on medical error this month as I work on getting my paper to the publishers and will recommend some steps to take for those of you who might be going into a hospital.


40% of U.S. Public Believes Quality of Care Has Worsened in Last Five Years
Many Say They or a Family Member Have Experienced Medical Error, Report Indicates
[Nov 18, 2004]

Four in 10 U.S. residents believe that the quality of health care in the United States has worsened in the past five years, despite widespread efforts by the health care industry to reduce medical errors following a 1999 Institute of Medicine report that attributed between 44,000 and 98,000 deaths annually to mistakes made in U.S. hospitals, according to a survey released Thursday by the Kaiser Family Foundation, Agency for Healthcare Research and Quality and the Harvard School of Public Health, the Scripps Howard/Detroit News reports (Bowman, Scripps Howard/Detroit News, 11/18).

Findings
For the survey -- which has a margin of error of plus or minus two percentage points -- researchers surveyed 2,012 randomly selected adults across the United States by phone from July 7 to Sept. 5. Findings are summarized below.

* Forty percent of the public believes that the quality of care in the United States has worsened in the past five years, compared with 38% who believe it has stayed the same and 17% who believe it has improved (May Yee, Minneapolis Star Tribune, 11/17).

* About 55% of the public are dissatisfied with the quality of care, up from 44% four years ago (Bloomberg, 11/17).

* Forty-eight percent of the public are concerned about the safety of medical care that they and their families receive (Minneapolis Star Tribune, 11/18).

* Thirty-four percent of the public say that either they or a family member have experienced a medical error at some point.

* People with chronic conditions were more likely to express concern about their quality of care and to report having experienced a medical error themselves or having a family member who did, according to the survey (Kaiser Family Foundation release, 11/17).

* Twenty-one percent of the public say they experienced a medical error that caused "serious health consequences," with 8% saying the result was death, 11% saying the result was long-term disability and 16% citing severe pain (Minneapolis Star Tribune, 11/18).

* Of those who experienced a medical error, nearly three in four say the physician has "a lot" of responsibility for the mistake, and 11% say they sued for malpractice. Among those who said the medical error resulted in serious health consequences, 14% sued for malpractice (Heil, CongressDaily, 11/17).

17 March 2005

Trends in Alternative Medicine



Trends in Alternative Medicine Use in the United States, 1990-1997
Results of a Follow-up National Survey
David M. Eisenberg, MD; Roger B. Davis, ScD; Susan L. Ettner, PhD; Scott Appel, MS; Sonja Wilkey; Maria Van Rompay; Ronald C. Kessler, PhD
JAMA. 1998;280:1569-1575.

Context A prior national survey documented the high prevalence and costs of alternative medicine use in the United States in 1990.
Objective To document trends in alternative medicine use in the United States between 1990 and 1997.
Design Nationally representative random household telephone surveys using comparable key questions were conducted in 1991 and 1997 measuring utilization in 1990 and 1997, respectively.
Participants A total of 1539 adults in 1991 and 2055 in 1997.
Main Outcomes Measures Prevalence, estimated costs, and disclosure of alternative therapies to physicians.
Results Use of at least 1 of 16 alternative therapies during the previous year increased from 33.8% in 1990 to 42.1% in 1997 (P<=.001). The therapies increasing the most included herbal medicine, massage, megavitamins, self-help groups, folk remedies, energy healing, and homeopathy. The probability of users visiting an alternative medicine practitioner increased from 36.3% to 46.3% (P=.002). In both surveys alternative therapies were used most frequently for chronic conditions, including back problems, anxiety, depression, and headaches. There was no significant change in disclosure rates between the 2 survey years; 39.8% of alternative therapies were disclosed to physicians in 1990 vs 38.5% in 1997. The percentage of users paying entirely out-of-pocket for services provided by alternative medicine practitioners did not change significantly between 1990 (64.0%) and 1997 (58.3%) (P=.36). Extrapolations to the US population suggest a 47.3% increase in total visits to alternative medicine practitioners, from 427 million in 1990 to 629 million in 1997, thereby exceeding total visits to all US primary care physicians. An estimated 15 million adults in 1997 took prescription medications concurrently with herbal remedies and/or high-dose vitamins (18.4% of all prescription users). Estimated expenditures for alternative medicine professional services increased 45.2% between 1990 and 1997 and were conservatively estimated at $21.2 billion in 1997, with at least $12.2 billion paid out-of-pocket. This exceeds the 1997 out-of-pocket expenditures for all US hospitalizations. Total 1997 out-of-pocket expenditures relating to alternative therapies were conservatively estimated at $27.0 billion, which is comparable with the projected 1997 out-of-pocket expenditures for all US physician services.
Conclusions Alternative medicine use and expenditures increased substantially between 1990 and 1997, attributable primarily to an increase in the proportion of the population seeking alternative therapies, rather than increased visits per patient.

16 March 2005

Paul Ewald: Infectious Disease and the Evolution of Virulence



One of the core issues in managing the human internal ecosystem with electromagnetic frequencies is tipping the balance in favor of more harmless organisms, i.e. find the bad guys and shoot them without harming the good citizens.

Professor Ewald articulates this as a public health strategy in the PBS series on Evolution:

Q: How does understanding the evolution of virulence help us to manage infectious disease?

A: For most of the last two centuries people have been using interventions to knock down infectious diseases as much as possible. The idea is that we're going to use weapons like vaccines and antibiotics or hygienic interventions to reduce the frequency of infection as much as possible.

My point is that there's another way of controlling these disease organisms. Instead of using these weapons -- antibiotics and vaccines and hygiene improvements -- as a way of knocking down the organism, we can use those interventions to control the evolution of the organisms instead of getting the organisms evolving around our interventions. We can get the organisms to evolve to be less harmful than they have been in the past. Essentially, what I'm saying is we can use interventions like vaccines or like hygienic improvements to domesticate these organisms.

That argument may seem a little bit surprising, but we've already domesticated organisms in many ways. One of the most obvious ways is when we make live vaccines in the laboratory. We're actually taking harmful organisms [and] changing the course of their evolution, making them evolve to be mild enough that we can then introduce them into people as a vaccine.

Professor Ewald comments on trying to avoid nosocomial infections in an Omni interview:

Omni: Can we avoid being infected at the hospital?

Ewald: Unfortunately, we're at the mercy of the hospital. When my daughter was born, in a good hospital in Washington State, my wife and I were appalled that a nurse stuck her finger in the baby's mouth to quiet her. We tried to explain why we didn't think it was a good idea, and she was offended. When we talked to the pediatrician, he got indignant and said, "I do it all the time myself."

Evolutionary Biology: What Doctors Don't Learn in Medical School

Many of the questions about electronic medicine can only be answered adequately by understanding that our body is like a rain forest with more foreign organisms than our own cells. The life and behavior of these visitors determines our health, longevity, mental stability, and affects everything about us and our lives. Ewald's book is the best introduction to evolutionary biology I have seen and there are clues interpersed throughout the book that will help those doing research on electromagnetic devices and healing. Highly recommended!



According to conventional wisdom, our genes and lifestyles are the most important causes of the most deadly ailments of our time. Conventional wisdom may be wrong. In this controversial book, the eminent biologist Paul W. Ewald offers some startling arguments:
  • Germs appear to be at the root of heart disease, Alzheimer's, schizophrenia, many forms of cancer, and other chronic diseases.
  • The greatest threats to our health come not from sensational killers such as Ebola, West Nile virus, and super-virulent strains of influenza, but from agents that are already here causing long-term infections, which eventually lead to debilitation and death.
  • The medical establishment has largely ignored the evidence that implicates these germs, to the detriment of public health.
  • New evolutionary theories are available, which explain how germs function and offer opportunities for controlling these modern plagues-if we are willing to listen to them.

11 March 2005


Arthritis after Vioxx®
The Media’s Focus on Prescription Pain Killers Ignores
Natural Remedies for Preventing and Treating Arthritis
By Richard P. Huemer, MD - LE Magazine February 2005

Last fall, doctors and patients were stunned by Merck’s voluntary worldwide withdrawal of its arthritis drug Vioxx® (rofecoxib) from the market, the largest prescription drug withdrawal in history. Vioxx® and other COX-2 (cyclooxygenase-2) inhibitors had been promoted as “wonder drugs” because of their ability to relieve arthritis pain without causing the stomach problems associated with other pain medications.

This startling decision to abandon Vioxx® followed the report of a significant increase in heart attacks and strokes among long-term users of the drug. An estimated 80 million people had taken Vioxx® by the time it was withdrawn, and annual sales of the drug exceeded $2.5 billion. The news media speculated on which drugs might fill the gap left by Vioxx®, while devoting curiously little attention to natural arthritis remedies.

Although Merck’s announcement came as a surprise to many, doubts about the drug had surfaced years earlier. In early 2001—less two years after the FDA approved Vioxx®—the FDA’s Advisory Committee on Arthritis met to discuss potential cardiovascular risks associated with Vioxx®.

Critics Blast FDA, Merck

Commenting on the 2001 FDA Advisory Committee meeting, Eric J. Topol, MD, wrote a stinging editorial in the October 21, 2004, issue of the New England Journal of Medicine, titled “Failing the Public Health—Rofecoxib, Merck, and the FDA.” Dr. Topol charged that the FDA never exercised its initiative to mandate a trial of rofecoxib (Vioxx®) and a similar drug, celecoxib (Celebrex®), in relation to their cardiovascular risks or benefits, despite evidence suggesting a correlation. Nor did Merck embrace the idea of conducting a trial to assess cardiovascular risk or benefit associated with Vioxx®. Instead, Merck sponsored educational symposia and commissioned medical articles to debunk the cardiovascular concerns associated with Vioxx®, while spending more than $100 million a year to promote the drug with direct-to-consumer advertising.

In November 2004, Dr. David Graham, associate director for science at the FDA’s Office of Drug Safety and a 20-year FDA scientist, testified before Congress about the FDA’s failure to protect the public health, calling the agency’s oversight of the drug “a profound regulatory failure.” Although concerns about the safety of Vioxx® had been building for several years, the FDA maintained that the drug’s benefits of providing pain relief with minimal gastrointestinal side effects warranted keeping it on the market, albeit with a warning about heart risks. Vioxx® was finally taken off the market on September 30, 2004, following the release of a study showing that the drug doubled the risk of heart attack and stroke in long-term users.

By this time, millions of Americans had used the drug, and Dr. Graham estimated that Vioxx® had caused 88,000-139,000 excess cases of heart attack and stroke. “I would argue the FDA as currently configured is incapable of protecting America against another Vioxx®. We are virtually defenseless,” said Dr. Graham. During his testimony, Dr. Graham noted that he felt pressured by supervisors to water down his findings from a study of patient insurance records indicating that Vioxx® increased heart attack risk. US Senate Finance Committee Chairman Charles Grassley, an Iowa Republican, said he worried that the FDA was “far too cozy” with drug companies, noting that an independent drug safety office might be needed.

Flu Alert: Chicago Flu


The second major flu of the season is going around and I now see cases in California, Chicago, Florida, Boston, Minnesota, and Washington, D.C. with the same frequencies. It is not as complex as the Florida flu but can be more serious as it contains a corona virus like SARS, although not as virulent. The flu package contains the usual parasite, typical virus, corona virus, candida, random organisms, and a flu signature frequency.

I call this the Chicago Flu since that is where I first saw it. There may be some variability in the parasite and virus strains. However, the F100 program below is working on about a dozen people.

repeat 7
dwell 720
duty 50
program b
vbackfreq a 8103.083928 0 50
converge .1 .001
vbackfreq a 403.42879 0 50
converge 1.9 .01
#2663667 flu signature frequency
6602.570374 #scalar octave
vbackfreq a 20.08554 0 50
converge 6 .01
33464 #corona virus
converge 18 .01
#386667 candida
19251.02 #scalar octave
converge 2.1 .01
converge 2.1 .01
#566675 666666 667666 445444 666346 567787 other organisms
28213.09 33191.35 33241.13 22177.35 33175.41 28268.45 #scalar octaves
#455655 365666 254536 164665 parasite
22685.73 18205.44 12672.60123 8198.187613 #scalar octaves
#367654 246556 166546 65656 #virus
18304.41 12275.30 8291.837088 3268.819761 #scalar octaves
end repeat

09 March 2005

Cells are younger than you think


How old cells can regain youth
Researchers find a youthful environment invigorates regeneration in old tissue
By Laura M Hrastar, New Scientist, February 17, 2005

Old cells may regain a youthful phenotype when exposed to a young cell environment, say researchers in Nature this week. The results, say the authors, indicate that aged satellite cells have an intrinsic ability to regenerate.

"We know old tissue repairs poorly, but it's not because there aren't stem cells ready to do the repair," coauthor Thomas Rando told The Scientist. "The problem is, with age, the environment the stem cells hit changes, [and] it makes them less responsive."

To study how systemic factors affect satellite cell regeneration, researchers from Stanford University and VA Palo Alto Health Care System in California created fusions of the circulatory systems of old mice and young mic-a technique known as parabiosis. The young mice were transgenic, expressing either green florescent protein or a distinct CD45 allele.

Five days after injuring the mice's hindlimbs, researchers found nucleated embryonic myosin heavy chain, a specific marker seen in regenerating myotube-nascent myofibers-in the old parabiotic animals. Because these cells did not contain transgenic markers, researchers determined that activation of resident progenitor cells-not engraftment of younger cells onto old tissue-was the cause of new growth.

Satellite cells in old parabiotic mice also showed similar upregulation as young mice controls of Notch ligand Delta, the binding protein necessary to activate the Notch signaling pathway for cell regeneration. The young parabiotic mice showed inhibition of Delta when compared with young mouse controls.

The new findings support the groups' previous work that showed the diminished expression of Delta related to age decreases Notch signaling, which reduces stem cell proliferation and impairs cell regeneration.

In the current study, researchers also found that culturing old satellite cells in young mouse serum restored upregulation of Notch ligand and Notch activation, whereas adding old mouse serum to young satellite cells inhibited the effect.

07 March 2005

Mediterranean Diet and Cancer Prevention


The antioxidant/anticancer potential of phenolic compounds isolated from olive oil
Owen RW, Giacosa A, Hull WE, Haubner R, Spiegelhalder B, Bartsch H.
Eur J Cancer. 2000 Jun;36(10):1235-47

In our ongoing studies on the chemoprevention of cancer we have a particular interest in the health benefits of the Mediterranean diet, of which olive oil is a major component. Recent studies have shown that extravirgin olive oil contains an abundance of phenolic antioxidants including simple phenols (hydroxytyrosol, tyrosol), aldehydic secoiridoids, flavonoids and lignans (acetoxypinoresinol, pinoresinol). All of these phenolic substances are potent inhibitors of reactive oxygen species attack on, e.g. salicylic acid, 2-deoxyguanosine. Currently there is growing evidence that reactive oxygen species are involved in the aetiology of fat-related neoplasms such as cancer of the breast and colorectum.

06 March 2005

Newletter March 2005

Every month, my new research, combined with new results published in the leading medical journals, provides new findings that expand the capabilities of electromagnetic fields for eliminating pathogens, improving cellular function, and generally enhancing health and well being. There is so much going on that a monthly update is becoming useful. Specifics on most of these items are found elsewhere on this web site.

My process for scanning and transmitting frequencies continues to improve:

1. Hardware – The inventor of the ABPA continues to provide enhanced cables for testing. The goal is to have a factory approved cable available to everyone at a future date. This cabling is at least five times more effective at getting power transfer to pathogens by remote transmission. The cable that comes with the ABPA should be connected to a frequency generator and run under the input well of the ABPA until a factory approved direct-connect cable is available.

2. Software - Carrier waves improve effectiveness and shorten treatment times by a factor of two using a special setup on the F160 frequency generator. Using scalar technology improves it by another factor of two. My software is four times as effective in transmitting frequencies remotely using the ABPA. Software and hardware enhancements are multiplicative in their effects.

3. Technique - Doing a full scan from 30mhz to 100hz identifies aberrant cell frequencies, pathogens, toxic proteins, and enzyme frequencies. Using an Anatomy atlas, pathogen locations can be targeted precisely.

4. Pathogen frequencies - For bacteria and viruses I am picking up toxin proteins released when they are killed. Targeting them with the pathogen significantly improves effect and eliminats most Herxheimer side effects often experienced. Viruses all have at least four specific frequencies. Bacteria have a primary frequency and a toxic protein frequency.

5. Enzyme frequencies have been developed for specific organ systems. These stimulate function of specific organs and provide a capability for the human body that has similar effects to an oil change and tuneup to your car.

6. A new strategy for fat burning has been developed. It is used with a specific green tea supplement which I recommend to everyone.

7. More research has been done on nanobacteria and new frequencies have been developed. My research shows these organisms are associated with everything from skin rashes to arthritis, heart disease, and cancer. Most people are infected with nanobacteria. The book, "The Calcium Bomb", is highly recommended reading.

8. Specific frequencies for atherosclerosis have been developed based on recent research in Europe which showed inoculating animals with Oxidized cholesterol prevented plaque buildup. This confirmed earlier research published in major journals showing heart disease is directly related to inflammation. My new finding is frequencies for the specific organisms that are causing the inflammation, a bacteria, nanobacteria, and a virus.

The result of this research is that my hardware setup is about 100 times as effective as most uses of the ABPA for frequency transmission. The ability to target pathogens in a specific organ with a precise frequency dramatically improves results.